| Literature DB >> 34853467 |
Arthi Shanmugavadivu1, Tommy Regen1, John B Grigg2,3,4, Christopher N Parkhurst2,3,4, Anees Ahmed2,3,4, Ann M Joseph2,3,4, Michael Mazzucco5, Konrad Gronke6,7, Andreas Diefenbach6,7, Gerard Eberl8, Timothy Vartanian5, Ari Waisman1, Gregory F Sonnenberg9,10,11.
Abstract
Pro-inflammatory T cells in the central nervous system (CNS) are causally associated with multiple demyelinating and neurodegenerative diseases1-6, but the pathways that control these responses remain unclear. Here we define a population of inflammatory group 3 innate lymphoid cells (ILC3s) that infiltrate the CNS in a mouse model of multiple sclerosis. These ILC3s are derived from the circulation, localize in proximity to infiltrating T cells in the CNS, function as antigen-presenting cells that restimulate myelin-specific T cells, and are increased in individuals with multiple sclerosis. Notably, antigen presentation by inflammatory ILC3s is required to promote T cell responses in the CNS and the development of multiple-sclerosis-like disease in mouse models. By contrast, conventional and tissue-resident ILC3s in the periphery do not appear to contribute to disease induction, but instead limit autoimmune T cell responses and prevent multiple-sclerosis-like disease when experimentally targeted to present myelin antigen. Collectively, our data define a population of inflammatory ILC3s that is essential for directly promoting T-cell-dependent neuroinflammation in the CNS and reveal the potential of harnessing peripheral tissue-resident ILC3s for the prevention of autoimmune disease.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34853467 PMCID: PMC8702489 DOI: 10.1038/s41586-021-04136-4
Source DB: PubMed Journal: Nature ISSN: 0028-0836 Impact factor: 69.504